Christy J. Oliger
Director, Karyopharm Therapeutics Inc.
Companies
- Zenas BioPharma, Inc.Board member Sep 2, 2026 to now1
- Bicara Therapeutics Inc.Board member Jul 29, 2026 to now2
- Nuvalent, Inc.Board member Jun 20, 2025 to now3
- LAVA Therapeutics NVBoard member Jan 2, 2025 to now4
- Vera Therapeutics, Inc.Board member Jun 11, 2024 to now5
- Replimune Group, Inc.Board member Dec 3, 2021 to now6
- Karyopharm Therapeutics Inc.Board member Aug 31, 2020 to now7
- RayzeBio, Inc.Board member Sep 14, 2023 to Feb 27, 20248
- REATA PHARMACEUTICALS INCBoard member Apr 15, 2021 to Sep 26, 20239
- Sierra Oncology, Inc.Board member Jun 4, 2021 to Jul 1, 202210
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Vera Therapeutics, Inc. VERA2,987 shares11$86.7K at $29.04Jun 11, 2024
- Karyopharm Therapeutics Inc. KPTI15,508 shares12$5.4K at $0.35May 21, 2026
- REATA PHARMACEUTICALS INC0 shares13Sep 26, 2023
- Nuvalent, Inc.0 shares14Jul 15, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Jul 15, 2026Returned to company 6,091 shares of Nuvalent, Inc.14
- Jul 15, 2026U 1,324 shares at $124.00 of Nuvalent, Inc.14
- Jun 16, 2026Granted 3,444 shares of Nuvalent, Inc.15
- May 21, 2026Granted 15,508 shares of Karyopharm Therapeutics Inc.12
- Jun 18, 2025Granted 3,971 shares of Nuvalent, Inc.16
- Sep 26, 2023Returned to company 5,565 shares of REATA PHARMACEUTICALS INC13
- Jun 7, 2023Granted 1,682 shares at $93.61 of REATA PHARMACEUTICALS INC17
- Jun 8, 2022Granted 3,883 shares at $34.76 of REATA PHARMACEUTICALS INC18
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARZenas BioPharma, Inc., Board member
- 2
- 3SEC EDGARNuvalent, Inc., Board member
- 4SEC EDGARLAVA Therapeutics NV, Board member
- 5
- 6SEC EDGARReplimune Group, Inc., Board member
- 7
- 8SEC EDGARRayzeBio, Inc., Board member
- 9
- 10SEC EDGARSierra Oncology, Inc., Board member
- 11
- 12
- 13
- 14
- 15SEC EDGARForm 4 filed Jun 18, 2026
- 16SEC EDGARForm 4 filed Jun 20, 2025
- 17SEC EDGARForm 4 filed Jun 9, 2023
- 18SEC EDGARForm 4 filed Jun 9, 2022